Nuvectis Pharma (NVCT) Q1 2026 Earnings

12FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.44
-0.38
-0.31
-0.25

Details

Expected EPS
-0.316
Actual EPS
-0.31
Surprise EPS
0.01
Surprise Percent
+1.9%

Description

Nuvectis Pharma (NVCT) has reported earnings of -0.31 per share for Q1 2026.

0 Comments

Share your thoughts